Medical weight loss is a doctor-supervised program that may include prescription GLP-1 medicine alongside diet, activity and follow-up visits.
California's Medi-Cal cutoff
The 2025-26 state budget ended Medi-Cal coverage of GLP-1s for adult weight loss from January 1, 2026. Members under 21 are still covered, and uses other than weight loss, such as diabetes, can be covered when medically necessary [1]. California was one of four states KFF identified as dropping obesity coverage after October 2025 [7].
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Beverly Hills, from $300 a month.
The listing shown is paid and labeled. We do not endorse sponsors. See sponsor a city.
Boutique pricing versus the drug's price
Beverly Hills' median household income is $132,977, compared with $81,939 in the City of Los Angeles [5]. Higher incomes can mean higher clinic price tags. The medicine itself costs the same everywhere: the manufacturer prices below are what any pharmacy charges a self-pay patient. Anything above that is the clinic's fee for visits, labs, body scans or add-on injections. Ask for those costs as separate line items.
| Drug | Monthly price | Source |
|---|---|---|
| Wegovy pill | $149 to $299 | [2] |
| Wegovy pen | $349 | [2] |
| Zepbound 7.5 to 15 mg | $449 (on-time refill) | [3] |
Academic programs nearby
UCLA Health's Medical Weight Management Program is a dedicated program; its overview page does not mention weight loss medicines, so ask whether they are part of it [6]. Cedars-Sinai is also nearby; we could not confirm details of a weight program there. Los Angeles County's adult obesity rate is 26.5% and diabetes rate 12.6% [4].
Medicare for older residents
A quarter of Beverly Hills residents, 25.4%, are 65 or older [5]. Medicare Part D enrollees who meet BMI-based rules can get Wegovy, Foundayo or the Zepbound KwikPen for $50 a month through the GLP-1 Bridge until December 31, 2027 [8]. Read GLP-1s and Medicare.
Other Southern California pages: Los Angeles, Orange County, San Diego. Also: medical weight loss, clinic checklist, online programs.
Read before starting
Wegovy and Zepbound have a boxed warning about thyroid C-cell tumors in rodents and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2 [9] [10]. Pancreatitis, gallbladder problems and allergic reactions are listed warnings, and pairing these drugs with insulin or a sulfonylurea raises the chance of low blood sugar. Stop when pregnancy is recognized. Compounded GLP-1s sold by some clinics are not FDA-approved [11]. Call 911 for emergencies.
Questions people ask
Does Medi-Cal cover Wegovy or Zepbound for weight loss?
Not for adults. Medi-Cal ended GLP-1 coverage for adult weight loss on Jan 1, 2026; members under 21 remain covered [1].
How much is medical weight loss in Beverly Hills?
Does UCLA's weight program prescribe GLP-1s?
UCLA's Medical Weight Management Program overview does not mention weight loss medicines, so ask the program directly [6].
What is the obesity rate in Los Angeles County?
CDC PLACES estimates 26.5% of LA County adults have obesity and 12.6% have diagnosed diabetes [4].
Can Medicare patients in Beverly Hills get GLP-1s?
Eligible Part D enrollees can get Wegovy, Foundayo or Zepbound KwikPen for $50 a month through the Medicare GLP-1 Bridge until Dec 31, 2027 [8].
Sources
11 cited
- California Medicaid ends coverage of GLP-1 weight loss drugs. KFF Health News, Jan 9, 2026.
- Wegovy self-pay offer, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- Zepbound self-pay prices on LillyDirect. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
- PLACES county data, 2025 release: Los Angeles County, CA. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
- QuickFacts: Beverly Hills city, California. U.S. Census Bureau, 2025 estimates and 2020-2024 ACS; accessed 2026-10-17.
- Medical Weight Management Program overview. UCLA Health, Oct 17, 2026.
- Medicaid coverage of and spending on GLP-1s. KFF, Jan 16, 2026.
- Weight loss drugs coverage (Medicare GLP-1 Bridge). Medicare.gov (CMS), Oct 17, 2026.
- Wegovy label (injection and tablets). DailyMed, National Library of Medicine, Jun 2026.
- Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration, Apr 2026.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.